St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
NCT05092022
Summary
This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.
Eligibility
Inclusion Criteria: * Eligible but out-of-date for cervical cancer screening * Able to speak, read, and communicate well in English or Spanish * Not at greater than average risk for cervical cancer Exclusion Criteria: * Pregnant * Incarcerated * Greater than average risk for cervical cancer, for example: * Already diagnosed with high-grade precancerous cervical cancer or cervical lesions * Has a compromised immune system * Unable to speak, read, and communicate well in English or Spanish * Unable or unwilling to give implied consent or otherwise complete study requirements
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05092022